Skip to main content
This website publishes administrative rules on their effective dates, as designated by the adopting state agencies, colleges, and universities.

Ohio Administrative Code Search

Busy
 
Keywords
:
1-719-323-9442
{"removedFilters":"","searchUpdateUrl":"\/ohio-administrative-code\/search\/update-search","keywords":"1-719-323-9442","start":4226,"pageSize":25,"sort":"BestMatch"}
Results 4,226 - 4,250 of 10,547
Sort Options
Sort Options
Rules
Rule
Rule 3701:1-58-33 | Training for uptake, dilution, and excretion studies.

...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-32 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement s...

Rule 3701:1-58-33 | Training for uptake, dilution, and excretion studies.

...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-32 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or a...

Rule 3701:1-58-34 | Use of unsealed radioactive material for imaging and localization studies for which a written directive is not required.

...irective under paragraph (B) of rule 3701:1-58-15 of the Administrative Code, a licensee may use any unsealed radioactive material prepared for medical use for imaging and localization studies that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or agreement state requirements; or (2) A PET ...

Rule 3701:1-58-35 | Permissible molybdenum-99, strontium-82, and strontium-85 concentrations.

... a radiopharmaceutical that contains: (1) More than 0.15 kilobecquerel of molybdenum-99 per megabecquerel of technetium-99m (0.15 microcurie of molybdenum-99 per millicurie of technetium-99m); or (2) More than 0.02 kilobecquerel of strontium-82 per megabecquerel of rubidium-82 chloride injection (0.02 microcurie of strontium-82 per millicurie of rubidium-82 chloride); or more than 0.2 kilobecquerel of strontium-85 ...

Rule 3701:1-58-35 | Permissible molybdenum-99, strontium-82, and strontium-85 concentrations.

... a radiopharmaceutical that contains: (1) More than 0.15 kilobecquerel of molybdenum-99 per megabecquerel of technetium-99m (0.15 microcurie of molybdenum-99 per millicurie of technetium-99m); or (2) More than 0.02 kilobecquerel of strontium-82 per megabecquerel of rubidium-82 chloride injection (0.02 microcurie of strontium-82 per millicurie of rubidium-82 chloride); or more than 0.2 kilobecque...

Rule 3701:1-58-36 | Training for imaging and localization studies.

...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized in rule 3701:1-58-34 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement state...

Rule 3701:1-58-36 | Training for imaging and localization studies.

...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized in rule 3701:1-58-34 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an a...

Rule 3701:1-58-37 | Use of unsealed radioactive material for which a written directive is required.

...required that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or agreement state requirements; or (2) A PET radioactive drug producer licensed in accordance with paragraph (I) of rule 3701:1-40-14 of the Administrative Code or equivalent United States nuclear regulatory commission or agreeme...

Rule 3701:1-58-37 | Use of unsealed radioactive material for which a written directive is required.

... material identified in paragraph (B)(1)(b)(vi) of rule 3701:1-58-40 the Administrative Code prepared for medical use and for which a written directive is required that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or agreement state requirements; or (2) A PET radioactive ...

Rule 3701:1-58-38 | Safety instruction for unsealed radioactive material.

...addition to the requirements of rule 3701:1-38-10 of the Administrative Code, (A) A licensee shall provide radiation safety instruction, initially and at least annually, to personnel caring for patients or human research subjects who cannot be released under rule 3701:1-58-30 of the Administrative Code. To satisfy this requirement, the instruction must be commensurate with the duties of the personnel and include: (...

Rule 3701:1-58-39 | Safety precautions for unsealed radioactive material.

...ct who cannot be released under rule 3701:1-58-30 of the Administrative Code, a licensee shall: (1) Quarter the patient or the human research subject either in: (a) A private room with a private sanitary facility; or (b) A room, with a private sanitary facility, with another individual who also has received therapy with unsealed radioactive material and who also cannot be released under rule 3701:1-58-30 of the Ad...

Rule 3701:1-58-40 | Training for use of unsealed radioactive material for which a written directive is required.

...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-37 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement st...

Rule 3701:1-58-40 | Training for use of unsealed radioactive material for which a written directive is required.

...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-37 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or a...

Rule 3701:1-58-40 | Training for use of unsealed radioactive material for which a written directive is required.

...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-37 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or a...

Rule 3701:1-58-41 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries).

...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries) to be a physician who: (A) Is certified by a medical specialty board whose certification process includes all of the requirements in par...

Rule 3701:1-58-41 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries).

...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries) to be a physician who: (A) Is certified by a medical specialty board whose certification process includes all of the require...

Rule 3701:1-58-42 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (thirty-three millicuries).

...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (thirty-three millicuries) to be a physician who: (A) Is certified by a medical specialty board whose certification process includes all of the requirements in paragraphs (...

Rule 3701:1-58-42 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (thirty-three millicuries).

...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (thirty-three millicuries) to be a physician who: (A) Is certified by a medical specialty board whose certification process includes all of the requirements in ...

Rule 3701:1-58-43 | Use of sources for manual brachytherapy.

...on provided the requirements of rule 3701:1-58-17 of the Administrative Code are met.

Rule 3701:1-58-43 | Use of sources for manual brachytherapy.

...equirements of paragraph (A) of rule 3701:1-58-17 of the Administrative Code are met.

Rule 3701:1-58-44 | Surveys after source implant and removal.

...of this rule in accordance with rule 3701:1-58-87 of the Administrative Code.

Rule 3701:1-58-45 | Brachytherapy sources accountability.

...countability in accordance with rule 3701:1-58-88 of the Administrative Code.

Rule 3701:1-58-46 | Safety instruction for manual brachytherapy.

...addition to the requirements of rule 3701:1-38-10 of the Administrative Code: (A) The licensee shall provide radiation safety instruction, initially and at least annually, to personnel caring for patients or human research subjects who are receiving brachytherapy and cannot be released under rule 3701:1-58-30 of the Administrative Code. To satisfy this requirement, the instruction must be commensurate with the dutie...

Rule 3701:1-58-47 | Safety precautions for manual brachytherapy.

...py and cannot be released under rule 3701:1-58-30 of the Administrative Code, a licensee shall: (1) Not quarter the patient or the human research subject in the same room as an individual who is not receiving brachytherapy; (2) Visibly post the patient's or human research subject's room with a "radioactive materials" sign; and (3) Note on the door or in the patient's or human research subject's chart where and how...

Rule 3701:1-58-48 | Calibration measurements of brachytherapy sources.

...herapy source, a licensee shall have: (1) Determined the source output or activity using a dosimetry system that meets the requirements of paragraph (A) of rule 3701:1-58-60 of the Administrative Code; (2) Determined source positioning accuracy within applicators; and (3) Used published protocols currently accepted by nationally recognized bodies to meet the requirements of paragraphs (A)(1) and (A)(2) of this rul...